Sage Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SAGE for the last quarter is 7.90 M USD, and it's 89.87% lower compared to the previous quarter. The net income of Q1 24 is -108.48 M USD.